Predicting and preventing bipolar disorder: the need to fundamentally advance the strategic approach
2014; Wiley; Volume: 16; Issue: 5 Linguagem: Inglês
10.1111/bdi.12216
ISSN1399-5618
AutoresRoger S. McIntyre, Christoph U. Correll,
Tópico(s)Schizophrenia research and treatment
ResumoBipolar DisordersVolume 16, Issue 5 p. 451-454 Editorial Predicting and preventing bipolar disorder: the need to fundamentally advance the strategic approach Roger S. McIntyre, Corresponding Author Roger S. McIntyre Department of Psychiatry, University of Toronto, Toronto, ON, Canada Department of Pharmacology, University of Toronto, Toronto, ON, Canada Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Institute of Medical Science, University of Toronto, Toronto, ON, Canada Corresponding author: Roger S. McIntyre, MD, FRCPC Department of Psychiatry and Pharmacology University of Toronto Mood Disorders Psychopharmacology Unit University Health Network 399 Bathurst Street Toronto, ON Canada M5T 2S8 Fax: 416-603-5368 E-mail: [email protected]Search for more papers by this authorChristoph Correll, Christoph Correll The Zucker Hillside Hospital, Psychiatry Research, North Shore–Long Island Jewish Health System, Glen Oaks, NY, USA Hofstra North Shore–LIJ School of Medicine, Hempstead, NY, USA The Feinstein Institute for Medical Research, North Shore–Long Island Jewish Health System, Glen Oaks, NY, USA Albert Einstein College of Medicine, Bronx, NY, USASearch for more papers by this author Roger S. McIntyre, Corresponding Author Roger S. McIntyre Department of Psychiatry, University of Toronto, Toronto, ON, Canada Department of Pharmacology, University of Toronto, Toronto, ON, Canada Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Institute of Medical Science, University of Toronto, Toronto, ON, Canada Corresponding author: Roger S. McIntyre, MD, FRCPC Department of Psychiatry and Pharmacology University of Toronto Mood Disorders Psychopharmacology Unit University Health Network 399 Bathurst Street Toronto, ON Canada M5T 2S8 Fax: 416-603-5368 E-mail: [email protected]Search for more papers by this authorChristoph Correll, Christoph Correll The Zucker Hillside Hospital, Psychiatry Research, North Shore–Long Island Jewish Health System, Glen Oaks, NY, USA Hofstra North Shore–LIJ School of Medicine, Hempstead, NY, USA The Feinstein Institute for Medical Research, North Shore–Long Island Jewish Health System, Glen Oaks, NY, USA Albert Einstein College of Medicine, Bronx, NY, USASearch for more papers by this author First published: 04 August 2014 https://doi.org/10.1111/bdi.12216Citations: 7Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1Murray CJ, Vos T, Lozano R et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2197– 2223. 2McIntyre RS, Konarski JZ. Bipolar disorder: a national health concern. CNS Spectr 2004; 9 (Suppl. 12): 6– 15. 3Collins PY, Patel V, Joestl SS et al. Grand challenges in global mental health. Nature 2011; 475: 27– 30. 4Polednak AP. Trends in bipolar disorder or depression as a cause of death on death certificates of US residents, 1999-2009. Soc Psychiatry Psychiatr Epidemiol 2013; 48: 1153– 1160. 5McMahon FJ, Insel TR. Pharmacogenomics and personalized medicine in neuropsychiatry. Neuron 2012; 74: 773– 776. 6Demyttenaere K, Bruffaerts R, Posada-Villa J et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA 2004; 291: 2581– 2590. 7Correll CU, Penzner JB, Lencz T et al. Early identification and high-risk strategies for bipolar disorder. Bipolar Disord 2007; 9: 324– 338. 8Malhi GS, Bargh DM, Coulston CM, Das P, Berk M. Predicting bipolar disorder on the basis of phenomenology: implications for prevention and early intervention. Bipolar Disord 2014; 16: 455– 470. 9Berk M, Brnabic A, Dodd S et al. Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention. Bipolar Disord 2011; 13: 87– 98. 10López-Jaramillo C, Lopera-Vásquez J, Gallo A et al. Effects of recurrence on the cognitive performance of patients with bipolar I disorder: implications for relapse prevention and treatment adherence. Bipolar Disord 2010; 12: 557– 567. 11Kessing LV, Nilsson FM. Increased risk of developing dementia in patients with major affective disorders compared to patients with other medical illnesses. J Affect Disord 2003; 73: 261– 269. 12Berk M, Berk L, Dodd S et al. Stage managing bipolar disorder. Bipolar Disord 2014; 16: 471– 477. 13Kapczinski F, Vieta E, Andreazza AC et al. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev 2008; 32: 675– 692. 14Rizzo LB, Costa LG, Mansur RB et al. The theory of bipolar disorder as an illness of accelerated aging: implications for clinical care and research. Neurosci Biobehav Rev 2014; 42C: 157– 169. 15Liu CS, Carvalho AF, Mansur RB, McIntyre RS. Obesity and bipolar disorder: synergistic neurotoxic effects? Adv Ther 2013; 30: 987– 1006. 16Correll CU, Hauser M, Penzner JB et al. Type and duration of subsyndromal symptoms in youth with bipolar I disorder prior to their first manic episode. Bipolar Disord 2014; 16: 478– 492. 17Bechdolf A, Ratheesh A, Cotton SM et al. The predictive validity of bipolar at-risk (prodromal) criteria in help-seeking adolescents and young adults: a prospective study. Bipolar Disord 2014; 16: 493– 504. 18Correll CU, Olvet DM, Auther AM et al. The Bipolar Prodrome Symptom Interview and Scale–Prospective (BPSS-P): description and validation in a psychiatric sample and healthy controls. Bipolar Disord 2014; 16: 505– 522. 19Strawn JR, Adler CM, McNamara RK et al. Antidepressant tolerability in anxious and depressed youth at high risk for bipolar disorder: a prospective naturalistic treatment study. Bipolar Disord 2014; 16: 523– 530. 20McIntyre RS, Cha DS, Jerrell JM et al. Advancing biomarker research: utilizing 'Big Data' approaches for the characterization and prevention of bipolar disorder. Bipolar Disord 2014; 16: 531– 547. 21Hauser M, Correll CU. The significance of at-risk or prodromal symptoms for bipolar I disorder in children and adolescents. Can J Psychiatry 2013; 58: 22– 31. 22Conus P, Macneil C, McGorry PD. Public health significance of bipolar disorder: implications for early intervention and prevention. Bipolar Disord 2014; 16: 548– 556. 23Frances A. Psychosis risk syndrome–far too risky. Aust N Z J Psychiatry 2011; 45: 803– 804. 24Correll CU. Clinical psychopharmacology of pediatric mood stabilizer and antipsychotic treatment, part 1: challenges and developments. J Clin Psychiatry 2007; 68: 1301– 1302. 25McIntyre RS. A vision for drug discovery and development: novel targets and multilateral partnerships. Adv Ther 2014; 31: 245– 246. Citing Literature Volume16, Issue5Special Issue: Guest Editors – Roger S. McIntyre and Christoph U. CorrellAugust 2014Pages 451-454 ReferencesRelatedInformation
Referência(s)